AMENORREA POR HIPERPROLACTINEMIA PDFAMENORREA POR HIPERPROLACTINEMIA PDF

Presentamos el caso de una paciente de 44 años estudiada por amenorrea e hiperprolactinemia. No refería galactorrea, cefalea ni alteraciones en la visión. HIPERPROLACTINEMIA Y PROLACTINOMA. MP Diagnóstico específico: PRL se deben medir en todo paciente con hipogonadismo o. A hiperprolactinemia causa hipogonadismo hipogonadotrófico principalmente por inibir a secreção pulsátil do GnRH, além de inibir diretamente a.

Author: Samukinos Tygom
Country: Turkey
Language: English (Spanish)
Genre: Automotive
Published (Last): 28 July 2011
Pages: 353
PDF File Size: 9.92 Mb
ePub File Size: 16.83 Mb
ISBN: 330-4-67762-534-3
Downloads: 41533
Price: Free* [*Free Regsitration Required]
Uploader: Mele

Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. Macroprolactinomas can also present with symptoms and signs resulting form mass effect of the tumor, such as headaches and visual field defects. Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulose cells.

Se houver um crescimento significativo do tumor, deve-se reintroduzir o AD.

їCabergolina o bromocriptina para el prolactinoma? – Medwave

Orphanet J Rare Dis. Pakistan Journal of Medical Sciences Online. Advances in the treatment of prolactinomas.

  ASCCP ALGORITHMS PDF

Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Prolactinomas in children and adolescents. Ribeiro RS, Abucham J. Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea.

Outcomes of transsphenoidal surgery in prolactinomas: De los estudios no aleatorizados incluidos, los tres corresponden a cohortes retrospectivas. Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney function tests in hyperprolactinemic women.

[Current diagnosis and treatment of hyperprolactinemia].

BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Trans Am Clin Climatol Assoc. Su principal desarrollo es la base de datos Epistemonikos www. Kluwer Academic Publishers; Radiotherapy for prolactin-secreting pituitary tumors.

Colao A, Loche S. Diagnosis and treatment of hyperprolactinemia: This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Patterns of visual loss associated with pituitary macroadenomas.

  CATALOGO AMPROBE PDF

Macroprolactinomas may cause cephalea, visual disturbance, and hypopituitarism. Todos los estudios compararon bromocriptina versus cabergolina. Cancer risk in hyperprolactinemia patients: Recentemente, Mazziotti e cols. Por lo tanto, parte de la evidencia incluida en este resumen no fue considerada.

J Clin Endocrinol Metab. A comparison of hiperprolactinemiia and bromocriptine on the risk of valvular heart disease in patients with prolactinomas. N Engl J Med. Quality of life in women with microprolactinoma treated with dopamine agonists. Aust N Z J Ophthalmol. Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.

High prevalence of radiological vertebral fractures in pir with prolactin-secreting pituitary adenomas.